2016
DOI: 10.1259/bjr.20160246
|View full text |Cite
|
Sign up to set email alerts
|

Single-centre experience of extending indications for percutaneous intraportal islet autotransplantation (PIPIAT) after pancreatic surgery to prevent diabetes: feasibility, radiological aspects, complications and clinical outcome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
4
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 41 publications
1
4
0
Order By: Relevance
“…PVT incidence after TPIAT at other institutions has been published in a few small series; contemporary incidence rates range from 0.9% to 4.2%. 14,40,41 This study’s PVT rate was slightly higher than those previous publications but is similar to published data from our group in an overlapping, but smaller and highly selected, TPIAT cohort from our center. 13 PVT rates in large non-TPIAT cohorts (>100 participants) after open splenectomy vary widely, ranging from 0.39% to 4.8%.…”
Section: Discussionsupporting
confidence: 90%
“…PVT incidence after TPIAT at other institutions has been published in a few small series; contemporary incidence rates range from 0.9% to 4.2%. 14,40,41 This study’s PVT rate was slightly higher than those previous publications but is similar to published data from our group in an overlapping, but smaller and highly selected, TPIAT cohort from our center. 13 PVT rates in large non-TPIAT cohorts (>100 participants) after open splenectomy vary widely, ranging from 0.39% to 4.8%.…”
Section: Discussionsupporting
confidence: 90%
“…Additional indications for autotransplant other than chronic pancreatitis are still controversial [27] and have been limited to the procedure performed only in small case series [28,29] of benign enucleable tumors or pancreatic trauma. Recently, broader selection criteria for autotransplant were suggested [30][31][32][33], exploring the possibility of extending autotransplant to patients with known malignancy, either having completion pancreatectomy as treatment for severe pancreatic fistulae or extensive distal pancreatectomy for neoplasms of the pancreatic neck or pancreatoduodenectomy because of high risk of pancreatic fistula.…”
Section: Islet Transplantation Todaymentioning
confidence: 99%
“…Islet transplantation demonstrated significant beneficial effects in the prevention/stabilization of diabetic complications [ 103 , 104 , 105 , 106 , 107 ]. Auto-transplantation was more recently introduced not to cure type 1 diabetes but to prevent another type of diabetes known as “pancreatogenic diabetes” [ 19 , 20 , 21 , 22 , 23 ]. The origin of pancreatogenic diabetes is caused from an extreme disruption of glucose homeostasis after extensive pancreatic resection such as subtotal/total pancreatectomy for tumors or chronic pancreatitis [ 108 , 109 , 110 , 111 , 112 ].…”
Section: Intra-portal Islet Auto-transplantationmentioning
confidence: 99%
“…Technically, allo- and auto-transplantation are similar procedures which are performed by interventional radiologists in the same way. Anyway, auto-transplantation is performed 12–48 h after pancreatic surgery: this peculiar situation may cause hemodynamic instability and a suboptimal ultrasound visibility due to residual abdominal air, which may hinder the procedure [ 21 ].…”
Section: Intra-portal Islet Auto-transplantationmentioning
confidence: 99%
See 1 more Smart Citation